AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 1096831 — intervention group
Group type: COMPARATOR
Intervention: Added sucrose formula
Number of subjects: 29
Study 30770586 — intervention group
Group type: EXPERIMENTAL
Intervention: Map-CT
Number of subjects: 96
Study 30770586 — intervention group
Group type: EXPERIMENTAL
Intervention: Eur-CT
Number of subjects: 96
Study 30770586 — intervention group
Group type: COMPARATOR
Intervention: Map-CG
Number of subjects: 96
Study 30770586 — intervention group
Group type: COMPARATOR
Intervention: Eur-CG
Number of subjects: 96
Study 28181920 — intervention group
Group type: EXPERIMENTAL
Intervention: Early rehabilitation program
Number of subjects: 53
Study 28181920 — intervention group
Group type: COMPARATOR
Intervention: Standard-care group (physical therapy as ordered by the primary care team)
Number of subjects: 53
Study 26234174 — intervention group
Group type: EXPERIMENTAL
Intervention: vosaroxin plus cytarabine
Number of subjects: 711
Study 26234174 — intervention group
Group type: COMPARATOR
Intervention: placebo plus cytarabine
Number of subjects: 711
Study 23714773 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin (80‐mg loading dose given a mean of 1.5 hours before percutaneous coronary intervention)
Number of subjects: 156
Study 23714773 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 156
Study 22120855 — intervention group
Group type: EXPERIMENTAL
Intervention: Eperisone 150 mg/day in three divided doses
Number of subjects: 240
Study 22120855 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 240
Study 19017422 — intervention group
Group type: EXPERIMENTAL
Intervention: alpha-lactalbumin breakfast
Number of subjects: 24
Study 19017422 — intervention group
Group type: COMPARATOR
Intervention: gelatin breakfast
Number of subjects: 24
Study 19017422 — intervention group
Group type: COMPARATOR
Intervention: gelatin+TRP breakfast
Number of subjects: 24
Study 19017422 — intervention group
Group type: COMPARATOR
Intervention: all diets
Number of subjects: 24
Study 16790638 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin (10 mg)
Number of subjects: 138
Study 16790638 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 138
Study 12760996 — intervention group
Group type: COMPARATOR
Intervention: Full-length circulating water mattress set at 42 degrees C
Number of subjects: 24
Study 12760996 — intervention group
Group type: COMPARATOR
Intervention: Lower-body forced-air cover with the blower set on high
Number of subjects: 24
Study 12760996 — intervention group
Group type: COMPARATOR
Intervention: Three-extremity carbon-fiber resistive-heating blanket set to 42 degrees C
Number of subjects: 24
Study 10672633 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol (0.26-0.28 g.kg-1)
Number of subjects: 0
Study 10672633 — intervention group
Group type: COMPARATOR
Intervention: Matched placebo drink
Number of subjects: 0
Study 9232961 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical tooth stimulus (EP-TS)
Number of subjects: 17
Study 9232961 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical finger stimulus (EP-FS)
Number of subjects: 17
Study 9232961 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical tooth stimulus (EP-TS) and Electrical finger stimulus (EP-FS)
Number of subjects: 17
Study 8469945 — intervention group
Group type: EXPERIMENTAL
Intervention: Inferential stimulation
Number of subjects: 20
Study 8469945 — intervention group
Group type: COMPARATOR
Intervention: Low-frequency stimulation
Number of subjects: 20
Study 2948929 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5% benzoyl peroxide
Number of subjects: 153
Study 2948929 — intervention group
Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 153
Study 2948929 — intervention group
Group type: COMPARATOR
Intervention: 5% benzoyl peroxide
Number of subjects: 153
Study 2948929 — intervention group
Group type: COMPARATOR
Intervention: 10% benzoyl peroxide
Number of subjects: 153
Study 30158423 — intervention group
Group type: EXPERIMENTAL
Intervention: TAS-102
Number of subjects: 2
Study 26439816 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 345
Study 26439816 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin
Number of subjects: 345
Study 26439816 — intervention group
Group type: COMPARATOR
Intervention: Diet-only
Number of subjects: 345
Study 25208500 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior endoscopic release (AER) followed by posterior instrumentation and correction
Number of subjects: 56
Study 25208500 — intervention group
Group type: COMPARATOR
Intervention: Posterior procedure without AER
Number of subjects: 56
Study 22986437 — intervention group
Group type: EXPERIMENTAL
Intervention: Linaclotide 290 μg once daily
Number of subjects: 804
Study 22986437 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 804
Study 20186437 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 mg melatonin
Number of subjects: 52
Study 20186437 — intervention group
Group type: COMPARATOR
Intervention: oral placebo
Number of subjects: 52
Study 19086332 — intervention group
Group type: EXPERIMENTAL
Intervention: Alosetron treatment for 3 weeks
Number of subjects: 17
Study 15708698 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 1959
Study 15708698 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1959
Study 12519139 — intervention group
Group type: EXPERIMENTAL
Intervention: Ilioinguinal/iliohypogastric nerve block
Number of subjects: 30
Study 12519139 — intervention group
Group type: COMPARATOR
Intervention: Caudal epidural block
Number of subjects: 30
Study 10471432 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 20
Study 10471432 — intervention group
Group type: COMPARATOR
Intervention: Medical treatment
Number of subjects: 20
Study 8933493 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise (5 min of cycling at 75% VO2max)
Number of subjects: 0
Study 8933493 — intervention group
Group type: COMPARATOR
Intervention: Quiet rest (30 min sitting quietly in a sound-dampened chamber)
Number of subjects: 0
Study 1654592 — intervention group
Group type: EXPERIMENTAL
Intervention: Ispaghula husk
Number of subjects: 29
Study 1654592 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 6130838 — intervention group
Group type: EXPERIMENTAL
Intervention: Baclofen
Number of subjects: 33
Study 6130838 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 28343553 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline plus ALA (600 mg) and n-3 PUFAs (docosahexaenoic acid 250 mg and eicosapentaenoic acid 16.67 mg)
Number of subjects: 84
Study 28343553 — intervention group
Group type: COMPARATOR
Intervention: Amitriptyline
Number of subjects: 84
Study 28343553 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline plus ALA and n-3 PUFAs
Number of subjects: 84
Study 27032639 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast (add-on therapy)
Number of subjects: 32
Study 27032639 — intervention group
Group type: COMPARATOR
Intervention: Standard steroid treatment only (LDS group)
Number of subjects: 32
Study 22628142 — intervention group
Group type: EXPERIMENTAL
Intervention: OROS methylphenidate
Number of subjects: 135
Study 22628142 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 135
Study 21411144 — intervention group
Group type: EXPERIMENTAL
Intervention: Face-to-face AED training programs
Number of subjects: 305
Study 21411144 — intervention group
Group type: COMPARATOR
Intervention: Video-based AED training programs
Number of subjects: 305
Study 21411144 — intervention group
Group type: COMPARATOR
Intervention: Face-to-face AED training programs emphasizing self-efficacy and perceived control
Number of subjects: 305
Study 21411144 — intervention group
Group type: COMPARATOR
Intervention: Video-based AED training programs emphasizing self-efficacy and perceived control
Number of subjects: 305
Study 19322661 — intervention group
Group type: EXPERIMENTAL
Intervention: Distress
Number of subjects: 146
Study 19322661 — intervention group
Group type: COMPARATOR
Intervention: Fear of the future
Number of subjects: 146
Study 17873192 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily routine chest radiographs (CXRs)
Number of subjects: 559
Study 17873192 — intervention group
Group type: COMPARATOR
Intervention: Clinically indicated CXRs
Number of subjects: 559
Study 17873192 — intervention group
Group type: COMPARATOR
Intervention: Abandoning daily routine CXRs
Number of subjects: 559
Study 15158627 — intervention group
Group type: EXPERIMENTAL
Intervention: WBRT and stereotactic radiosurgery
Number of subjects: 333
Study 15158627 — intervention group
Group type: COMPARATOR
Intervention: WBRT alone
Number of subjects: 333
Study 11701433 — intervention group
Group type: COMPARATOR
Intervention: Oral estrogen
Number of subjects: 8
Study 9812772 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine 150 micrograms
Number of subjects: 40
Study 9812772 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine 75 micrograms
Number of subjects: 40
Study 9812772 — intervention group
Group type: EXPERIMENTAL
Intervention: Sumatriptan 6 mg
Number of subjects: 40
Study 9812772 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine 75 micrograms + Sumatriptan 3 mg
Number of subjects: 40
Study 9812772 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 40
Study 7702795 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous E-3174 (20 mg infused over 4 h)
Number of subjects: 0
Study 7702795 — intervention group
Group type: COMPARATOR
Intervention: Placebo (vehicle)
Number of subjects: 0
Study 7702795 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous E-3174
Number of subjects: 0
Study 3667138 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural anaesthesia
Number of subjects: 36
Study 3667138 — intervention group
Group type: COMPARATOR
Intervention: General anaesthesia
Number of subjects: 36
Study 30005332 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-regulation strategies following moderate intensity exercise
Number of subjects: 40
Study 30005332 — intervention group
Group type: COMPARATOR
Intervention: 20 min moderate intensity exercise
Number of subjects: 40
Study 30005332 — intervention group
Group type: COMPARATOR
Intervention: 20 min video (neutral condition)
Number of subjects: 40
Study 30422443 — intervention group
Group type: EXPERIMENTAL
Intervention: Endobronchial photodynamic therapy based on fluorescent diagnostics of photosensibilizator accumulation.
Number of subjects: 90
Study 30422443 — intervention group
Group type: COMPARATOR
Intervention: Standard method of photodynamic therapy.
Number of subjects: 90
Study 25499939 — intervention group
Group type: EXPERIMENTAL
Intervention: Xuezhikang 1200 mg daily
Number of subjects: 116
Study 25499939 — intervention group
Group type: EXPERIMENTAL
Intervention: Xuezhikang 2400 mg daily
Number of subjects: 116
Study 25499939 — intervention group
Group type: EXPERIMENTAL
Intervention: Xuezhikang
Number of subjects: 116
Study 25499939 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 116
Study 22479368 — intervention group
Group type: EXPERIMENTAL
Intervention: Financial incentive group (subsidized price of $55)
Number of subjects: 258
Study 22479368 — intervention group
Group type: COMPARATOR
Intervention: Control group (co-payment of $330-660)
Number of subjects: 258
Study 22479368 — intervention group
Group type: EXPERIMENTAL
Intervention: Financial incentive group
Number of subjects: 258
Study 22479368 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 258
Study 20044689 — intervention group
Group type: EXPERIMENTAL
Intervention: Cemented Thompson hemiarthroplasty
Number of subjects: 400
Study 18007158 — intervention group
Group type: EXPERIMENTAL
Intervention: iopamidol-370
Number of subjects: 166
Study 18007158 — intervention group
Group type: COMPARATOR
Intervention: iodixanol-320
Number of subjects: 166
Study 16121514 — intervention group
Group type: EXPERIMENTAL
Intervention: Hochuekkito
Number of subjects: 15
Study 16121514 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 12358134 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise (3 days per week of stationary bicycling for 45 min at 50-60% of heart rate reserve)
Number of subjects: 35
Study 12358134 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 35
Study 12358134 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 35
Study 10404442 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse home visiting programme supported by a social worker and paediatrician
Number of subjects: 181
Study 10404442 — intervention group
Group type: COMPARATOR
Intervention: Standard community child health services
Number of subjects: 181
Study 7488277 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose cyclosporine
Number of subjects: 0
Study 7488277 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 2317014 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-AP (10 to 25 mg)
Number of subjects: 20
Study 2317014 — intervention group
Group type: COMPARATOR
Intervention: Placebo (lactose capsules)
Number of subjects: 20
Study 396053 — intervention group
Group type: COMPARATOR
Intervention: Praziquantel (1x20, 2x20, or 3x20 mg/kg)
Number of subjects: 79
Study 396053 — intervention group
Group type: EXPERIMENTAL
Intervention: Praziquantel (three oral doses of 20 mg/kg at 4-hour intervals)
Number of subjects: 79
Study 396053 — intervention group
Group type: EXPERIMENTAL
Intervention: Praziquantel (single oral dose of 50 mg/kg)
Number of subjects: 79
Study 396053 — intervention group
Group type: EXPERIMENTAL
Intervention: Praziquantel (treatment)
Number of subjects: 79
Study 396053 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 79
Study 31937342 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-chamber syringe
Number of subjects: 146
Study 31937342 — intervention group
Group type: COMPARATOR
Intervention: Classic syringes
Number of subjects: 146
Study 31495374 — intervention group
Group type: EXPERIMENTAL
Intervention: Methadone
Number of subjects: 0
Study 31495374 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine
Number of subjects: 0
Study 31495374 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone
Number of subjects: 0
Study 31495374 — intervention group
Group type: COMPARATOR
Intervention: No treatment or treatment without medications
Number of subjects: 0
Study 28606657 — intervention group
Group type: EXPERIMENTAL
Intervention: FGF‐2 plus Gelfoam patch
Number of subjects: 138
Study 28606657 — intervention group
Group type: EXPERIMENTAL
Intervention: Gelfoam patch alone
Number of subjects: 138
Study 28606657 — intervention group
Group type: COMPARATOR
Intervention: Observation alone
Number of subjects: 138
Study 26061609 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal estradiol (E2)
Number of subjects: 0
Study 26061609 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline (SERT)
Number of subjects: 0
Study 26061609 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 0
Study 23238653 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant supplementation
Number of subjects: 103
Study 23238653 — intervention group
Group type: COMPARATOR
Intervention: Placebo supplement
Number of subjects: 103
Study 21330451 — intervention group
Group type: EXPERIMENTAL
Intervention: Agility and perturbation training with standard exercise therapy
Number of subjects: 183
Study 21330451 — intervention group
Group type: COMPARATOR
Intervention: Standard exercise program alone
Number of subjects: 183
Study 19847724 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-treatment counselling
Number of subjects: 166
Study 19847724 — intervention group
Group type: COMPARATOR
Intervention: No pre-treatment counselling (control group)
Number of subjects: 166
Study 15961713 — intervention group
Group type: EXPERIMENTAL
Intervention: Levofloxacin (500 mg/100 mL/d for 3 days)
Number of subjects: 136
Study 15961713 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.9% physiological serum)
Number of subjects: 136
Study 15961713 — intervention group
Group type: EXPERIMENTAL
Intervention: Levofloxacin
Number of subjects: 136
Study 15961713 — intervention group
Group type: COMPARATOR
Intervention: Optimal care
Number of subjects: 136
Study 12568978 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulphide sensor system measuring sulcular sulphide levels (SU)
Number of subjects: 63
Study 10616985 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic vein harvest (EVH)
Number of subjects: 100
Study 10616985 — intervention group
Group type: COMPARATOR
Intervention: Open vein harvesting (OVH)
Number of subjects: 100
Study 8565025 — intervention group
Group type: EXPERIMENTAL
Intervention: Clindamycin hydrochloride 150 mg QID for 10 days
Number of subjects: 164
Study 8565025 — intervention group
Group type: COMPARATOR
Intervention: Clindamycin hydrochloride 300 mg BID plus placebo BID for 10 days
Number of subjects: 164
Study 1726893 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction chemotherapy for osteosarcoma (4 or 9 weeks) with high doses of methotrexate, vincristine, and citrovorum factor rescue or BCD (bleomycin, cytoxan, actinomycin D) and CDDP (cisplatin).
Number of subjects: 0
Study 1726893 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance chemotherapy continued for up to 2 years.
Number of subjects: 0
Study 1726893 — intervention group
Group type: EXPERIMENTAL
Intervention: Ewing's sarcoma treated with T-9 Rosen's regimen or Memphis group regimen.
Number of subjects: 0
Study 1726893 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy for primary tumor with doses adjusted to tumor response (30-50 Gy or 50 Gy).
Number of subjects: 0
Study 7034472 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium nitroprusside infusion during 24 hours, followed by six times a day 5 mg isosorbide dinitrate for seven days
Number of subjects: 328
Study 7034472 — intervention group
Group type: COMPARATOR
Intervention: Glucose 5% infusion
Number of subjects: 328
Study 31816103 — intervention group
Group type: EXPERIMENTAL
Intervention: An Individualized Mental Health Intervention for Autism Spectrum Disorder (AIM HI)
Number of subjects: 46
Study 30914334 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of basal cell hyperplasia (BCH) in baseline prostate biopsy
Number of subjects: 6471
Study 30914334 — intervention group
Group type: EXPERIMENTAL
Intervention: BCH in baseline biopsy
Number of subjects: 6471
Study 28708285 — intervention group
Group type: EXPERIMENTAL
Intervention: Green light (G-group)
Number of subjects: 750
Study 28708285 — intervention group
Group type: COMPARATOR
Intervention: Darkness (D-group)
Number of subjects: 750
Study 28708285 — intervention group
Group type: COMPARATOR
Intervention: Red light (R-group)
Number of subjects: 750
Study 25240787 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived cognitive ability (PCA)
Number of subjects: 88
Study 25240787 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived cognitive impairment (PCI)
Number of subjects: 88
Study 23317527 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (CPFX) 300 mg every 12h
Number of subjects: 51
Study 23317527 — intervention group
Group type: COMPARATOR
Intervention: Cefepime (CFPM) 2g every 12h
Number of subjects: 51
Study 23317527 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (CPFX)
Number of subjects: 51
Study 23317527 — intervention group
Group type: COMPARATOR
Intervention: Cefepime (CFPM)
Number of subjects: 51
Study 23317527 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (CPFX) and Cefepime (CFPM)
Number of subjects: 51
Study 21277924 — intervention group
Group type: EXPERIMENTAL
Intervention: Kid's Choice Program (KCP)
Number of subjects: 382
Study 21277924 — intervention group
Group type: COMPARATOR
Intervention: Control group (Good Citizenship Behaviors)
Number of subjects: 382
Study 19297117 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavior Therapy (CBT) intervention
Number of subjects: 94
Study 17115380 — intervention group
Group type: EXPERIMENTAL
Intervention: Sumanirole 1 to 48 mg/day
Number of subjects: 948
Study 17115380 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropinirole 0.75 to 24 mg/day
Number of subjects: 948
Study 17115380 — intervention group
Group type: COMPARATOR
Intervention: Sumanirole
Number of subjects: 948
Study 16030435 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 g alcohol per day for 8 weeks
Number of subjects: 0
Study 16030435 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 g alcohol per day for 8 weeks
Number of subjects: 0
Study 16030435 — intervention group
Group type: COMPARATOR
Intervention: 0 g alcohol (control group)
Number of subjects: 0
Study 11908559 — intervention group
Group type: COMPARATOR
Intervention: Sedentary controls
Number of subjects: 93
Study 11205831 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold application
Number of subjects: 60
Study 7535952 — intervention group
Group type: EXPERIMENTAL
Intervention: Concomitant chemoradiotherapy
Number of subjects: 0
Study 7535952 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitomycin C, cisplatin, and 5‐fluorouracil
Number of subjects: 0
Study 7535952 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated hyperfractionation with or without chemotherapy
Number of subjects: 0
Study 7535952 — intervention group
Group type: EXPERIMENTAL
Intervention: Reirradiation with concomitant chemotherapy
Number of subjects: 0
Study 7535952 — intervention group
Group type: EXPERIMENTAL
Intervention: Concomitant, alternating or split course chemoradiotherapy
Number of subjects: 0
Study 7535952 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 1681960 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin or non-aspirin NSAIDs
Number of subjects: 0
Study 1681960 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-secretory drugs and prostaglandins
Number of subjects: 0
Study 1681960 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term studies in humans
Number of subjects: 0
Study 1681960 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 7008819 — intervention group
Group type: COMPARATOR
Intervention: 0.5% bupivacaine 3 ml with no glucose
Number of subjects: 0
Study 7008819 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine 3 ml with 5% glucose
Number of subjects: 0
Study 7008819 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine 3 ml with 8% glucose
Number of subjects: 0
Study 31996053 — intervention group
Group type: EXPERIMENTAL
Intervention: Medicated chewing gum (MCG) with taste-masked LCZ (drug/Kleptose complex 1:3 molar ratio)
Number of subjects: 0